Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,999Revenue $M4,061Net Margin (%)4.8Altman Z-Score3.3
Enterprise Value $M29,274EPS $1.8Operating Margin %17.0Piotroski F-Score5
P/E(ttm)125Beneish M-Score-2.7Pre-tax Margin (%)6.1Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %21.5Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow29.3y-y EBITDA Growth Rate %11.1ROA % (ttm)1.4Higher Current Ratio y-yY
Dividend Yield %0.2PEG5.6ROE % (ttm)2.3Less Shares Outstanding y-yN
Payout Ratio %30.0Shares Outstanding M146ROIC % (ttm)5.6Gross Margin Increase y-yN

Gurus Latest Trades with PRGO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRGOVanguard Health Care Fund 2015-06-30 Reduce-0.26%$163.73 - $203.69
($190.23)
$ 191.431%Reduce 18.83%3,129,532
PRGOKen Fisher 2015-06-30 Reduce-0.08%$163.73 - $203.69
($190.23)
$ 191.431%Reduce 49.28%233,870
PRGOMariko Gordon 2015-03-31 Sold Out -0.21%$147.77 - $173.7
($159.5)
$ 191.4320%Sold Out0
PRGORuane Cunniff 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 191.4320%Reduce 0.06%1,698,713
PRGORon Baron 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 191.4320%Reduce 3.18%76,494
PRGOJohn Keeley 2015-03-31 Add$147.77 - $173.7
($159.5)
$ 191.4320%Add 2.32%30,731
PRGOKen Fisher 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 191.4320%Reduce 0.90%461,071
PRGOVanguard Health Care Fund 2014-12-31 Add0.21%$145.69 - $168.76
($156.26)
$ 191.4323%Add 16.64%3,855,652
PRGOJoel Greenblatt 2014-12-31 Sold Out $145.69 - $168.76
($156.54)
$ 191.4322%Sold Out0
PRGOVanguard Health Care Fund 2014-09-30 Add0.04%$139 - $158.85
($149.11)
$ 191.4328%Add 2.96%3,305,652
PRGOJoel Greenblatt 2014-09-30 Buy $139 - $158.85
($149.08)
$ 191.4328%New holding1,665
PRGORon Baron 2014-09-30 Add$139 - $158.85
($149.11)
$ 191.4328%Add 1.19%79,307
PRGOJohn Keeley 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 191.4328%Reduce 1.08%30,263
PRGORuane Cunniff 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 191.4328%Reduce 0.37%1,710,706
PRGOKen Fisher 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 191.4328%Reduce 1.79%477,504
PRGOGeorge Soros 2014-06-30 Sold Out -0.13%$126.87 - $157.2
($141.62)
$ 191.4335%Sold Out0
PRGOVanguard Health Care Fund 2014-06-30 Add0.04%$126.87 - $157.2
($141.89)
$ 191.4335%Add 3.76%3,210,552
PRGOMariko Gordon 2014-06-30 Reduce$126.87 - $157.2
($141.89)
$ 191.4335%Reduce 0.09%28,494
PRGOKen Fisher 2014-06-30 Add$126.87 - $157.2
($141.89)
$ 191.4335%Add 0.49%486,226
PRGORuane Cunniff 2014-06-30 Reduce$126.87 - $157.2
($141.89)
$ 191.4335%Reduce 0.11%1,717,063
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRGO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PRGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KINGMA TODD WExecutive VP, General Counsel 2015-04-29Sell1,700$190.271.35view
HENDRICKSON JOHN TEVP Global Operations & Supply 2015-04-14Sell8,800$200.27-3.71view
KINGMA TODD WExecutive VP, General Counsel 2015-04-13Sell1,300$198.44-2.83view
Shah JatinSr VP & Chief Scientific Offic 2015-03-13Sell2,000$165.516.51view
Yu LouisExecutive VP Global Quality 2015-03-12Sell140$166.2715.97view
Farrington ThomasSenior VP and CIO 2015-02-20Sell517$151.1827.55view
MORRIS HERMAN JRDirector 2014-11-14Sell200$154.4224.87view
Kochan SharonEVP, GM International 2014-11-10Sell5,367$156.3623.32view
Yu LouisExecutive VP Global Quality 2014-11-10Sell259$155.1124.32view
O'Connor DonalDirector 2014-11-04Sell0$024.32view

Quarterly/Annual Reports about PRGO:

News about PRGO:

Articles On GuruFocus.com
Perrigo Company Is Strong But Overvalued Jul 15 2015 
KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
Mariko Gordon Sells Lumber Liquidators, Western Digital May 19 2015 
Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
Teva Eyeing Mylan For $40 Billion Apr 23 2015 
CalAmp and Illumina Significant Earnings Growth; Perrigo Rebuffs Takeover Offer Apr 22 2015 
Weekly 52-Week Highs Highlight: BLK, HIG, PRGO, NKE Mar 23 2015 
Fournier Finds Time for His Own Investments in the Third Quarter Dec 17 2014 
David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
David Rolfe Comments on Perrigo Jan 27 2014 

More From Other Websites
Analysts ask if Mylan can make case with its shareholders for Perrigo purchase Jul 29 2015
Mylan gets EU clearance for Perrigo clearance Jul 29 2015
Mylan gets European clearance in proposed Perrigo takeover Jul 29 2015
Mylan gets European clearance in proposed Perrigo takeover Jul 29 2015
Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of... Jul 29 2015
EU clears acquisition of Perrigo by Mylan Jul 29 2015
More tie-ups in generic drug cos expected Jul 28 2015
There's 'Life After Teva' For Mylan, Says Leerink Jul 28 2015
Faber Report: Mylan continues fight for Perrigo Jul 28 2015
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion Jul 28 2015
Mylan independence from Teva's embrace comes with a price Jul 27 2015
Mylan independence from Teva's embrace comes with a price Jul 27 2015
Teva Tags Allergan's Generics: $40.5 Bil Jul 27 2015
Mylan to gather shareholders Aug. 28 in Amsterdam to decide Perrigo bid Jul 27 2015
Analysts expect more tie-ups in generic drug business Jul 27 2015
Analysts expect more tie-ups in generic drug business Jul 27 2015
Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders Jul 27 2015
Mylan must raise its bid for Perrigo Jul 27 2015
With Teva out of the way, Mylan clear to focus on Perrigo deal Jul 27 2015
Allergan to own 10% stake in Teva Jul 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK